Multiple sclerosis after treatment with anti-TNF-α antibodies [5];Esclerosis múltiple tras tratamiento con anticuerpo anti-TNF-α

Medicina Clinica

Volumn 125, Issue 19, 2005, Pages 759-

  Munteis Olivas, Elvira ^a   Pérez García, Carolina ^a   Roquer González, Jaume ^a   Maymo Guarch, Joan ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; CASE REPORT; FEMALE; HUMAN; LETTER; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; RHEUMATOID ARTHRITIS;

EID: 29444459258     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(05)72181-3     Document Type: Letter

References (10)

1. Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 1995;5:392-9.
2. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature. 1995;377:348-51.
3. Segal BM, Cross AH. Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination. Neurology. 2000;55:906-7.
4. Raza A. Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes. Microsc Res Tech. 2000;50:229-35.
5. Van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, Von Blomberg BM, et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal antitumor necrosis factor antibody cA2. Neurology. 1996;47:1531-4.
6. The Lenercept Multiple Sclerosis study group and the University of British Columbia MS/MRI. Analysis group TNF neutralisation in MS: results of a randomized, placebo-controlled multicenter study. Neurology. 1999;53:457-65.
7. Poser CM, Paty DW, Sheinberg LC, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis guidelines for research protocols. Ann neurol. 1983;13:227-31.
8. Mc Donald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lubin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50: 121-7.
9. Mohan N, Edwards ET, Cupps TR, Oliveiro PJ, Sandberg G, Crayton H, et al. Demyelination ocurring during anti-tumor necrosis factor (therapy for inflammatory arthritides. Arthritis Rheum. 2001;44:2862-9.
10. Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology. 2001;57:1885-8.